Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) Total Current Liabilities (2020 - 2026)

Canton Strategic Holdings' (CNTN) quarterly Total Current Liabilities came in at $1.1 million in Q1 2026, down 53.9% YoY from $2.5 million in Q1 2025, and down 65.27% on a QoQ basis from $3.3 million in Q4 2025.

Analysis

Canton Strategic Holdings (CNTN) Total Current Liabilities (2020 - 2026) Analysis & Trends

Canton Strategic Holdings (CNTN) has 7 years of Total Current Liabilities data on file, last reported at $1.1 million in Q1 2026.

  • Quarterly Total Current Liabilities fell 53.9% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 53.9% YoY) and the FY2025 annual result came in at $3.3 million, up 36.14% from the prior year.
  • Total Current Liabilities fell to $1.1 million in Q1 2026, from $3.3 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $3.3 million in Q4 2025 to a low of $902348.0 in Q3 2022.
  • A 5-year average of $1.8 million and a median of $1.6 million in 2024 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Current Liabilities slumped 74.75% — and 2023, when it soared 58.52%.
  • Tracing CNTN's Total Current Liabilities over 5 years: stood at $1.1 million in 2022, then soared by 58.52% to $1.8 million in 2023, then surged by 33.0% to $2.4 million in 2024, then soared by 36.14% to $3.3 million in 2025, then plunged by 65.27% to $1.1 million in 2026.
  • The last three Total Current Liabilities figures came in at $1.1 million (Q1 2026), $3.3 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.58 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.53 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 354.06 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 2.12 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.51 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 630.93 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 438.74 Mn
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn - 2.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.63 Mn
Mar 31, 2026 1.14 Mn
Dec 31, 2025 3.29 Mn
Sep 30, 2025 1.54 Mn
Jun 30, 2025 2.16 Mn
Mar 31, 2025 2.48 Mn
Dec 31, 2024 2.41 Mn
Sep 30, 2024 2.23 Mn
Jun 30, 2024 1.56 Mn
Mar 31, 2024 1.84 Mn
Dec 31, 2023 1.82 Mn
Sep 30, 2023 1.41 Mn
Jun 30, 2023 1.53 Mn
Mar 31, 2023 1.52 Mn
Dec 31, 2022 1.14 Mn
Sep 30, 2022 902,348.00
Jun 30, 2022 1.21 Mn
Mar 31, 2022 1.75 Mn
Dec 31, 2021 4.53 Mn
Dec 31, 2020 2.73 Mn